Evidence map›Paper›PMID 36834964›Full record

ArticleInternational journal of molecular sciences2023

First Synthesis of DBU-Conjugated Cationic Carbohydrate Derivatives and Investigation of Their Antibacterial and Antifungal Activity.

Fruzsina Demeter, Patrik Török, Alexandra Kiss, Richárd Kovásznai-Oláh, Zsuzsa Máthéné Szigeti, Viktória Baksa, Fruzsina Kovács, Noémi Balla, Ferenc Fenyvesi, Judit Váradi and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Fruzsina DemeterDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Patrik TörökDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Alexandra KissInstitute of Biotechnology, Faculty of Science and Technology, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Richárd Kovásznai-OláhInstitute of Biotechnology, Faculty of Science and Technology, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Zsuzsa Máthéné SzigetiInstitute of Biotechnology, Faculty of Science and Technology, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Viktória BaksaInstitute of Biotechnology, Faculty of Science and Technology, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Fruzsina KovácsDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
Noémi BallaDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
Ferenc FenyvesiDepartment of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary.ORCID 0000-0003-2890-0783
Judit VáradiDepartment of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary.ORCID 0000-0003-1885-164X
Anikó BorbásDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.ORCID 0000-0001-8462-4547
Mihály HerczegDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.ORCID 0000-0002-7938-9789
University of Debrecen · HU

Funding

European Regional Development Fund GINOP-2.3.4-15-2020-00008National Research and Development and Innovation Office of Hungary FK 137924National Research and Development and Innovation Office of Hungary K 132870
6 · The paper itself

Abstract

The emergence of drug-resistant bacteria and fungi represents a serious health problem worldwide. It has long been known that cationic compounds can inhibit the growth of bacteria and fungi by disrupting the cell membrane. The advantage of using such cationic compounds is that the microorganisms would not become resistant to cationic agents, since this type of adaptation would mean significantly altering the structure of their cell walls. We designed novel, DBU (1,8-diazabicyclo[5.4.0]undec-7-ene)-derived amidinium salts of carbohydrates, which may be suitable for disturbing the cell walls of bacteria and fungi due to their quaternary ammonium moiety. A series of saccharide-DBU conjugates were prepared from 6-iodo derivatives of d-glucose, d-mannose, d-altrose and d-allose by nucleophilic substitution reactions. We optimized the synthesis of a d-glucose derivative, and studied the protecting group free synthesis of the glucose-DBU conjugates. The effect of the obtained quaternary amidinium salts against

Indexed as

Antifungal AgentsSaltsAnti-Bacterial AgentsBacteriaCarbohydratesFungiGlucoseMicrobial Sensitivity TestsQuaternary Ammonium CompoundsStructure-Activity RelationshipSugarsAnti-Bacterial AgentsAntifungal AgentsCarbohydratesGlucoseQuaternary Ammonium CompoundsSaltsSugarsamidinium saltantibacterialantifungalcationic carbohydratequaternary ammonium compound

Identifiers

PMID36834964
PMCPMC9968064
OpenAlexW4319985667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.